May 14, 2007

U.S. NCI Files for Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)

May 2, 2007

Oncolytics Biotech Inc. Announces Details of 2007 Annual Shareholder Meeting

Apr 30, 2007

Oncolytics Biotech Inc. Successfully Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R)

Apr 27, 2007

Oncolytics Biotech Inc. Announces 2007 First Quarter Results

Apr 17, 2007

Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect Against Human Colon Cancer Cell Lines

Apr 11, 2007

Oncolytics Biotech Inc. Proceeds to Initiate U.S. Phase II Sarcoma Clinical Trial

Apr 3, 2007

Oncolytics Biotech Inc. Announces Issuance of 20th U.S. Patent

Mar 21, 2007

Oncolytics Biotech Inc. Announces Closing of Over-Allotment Option

Mar 19, 2007

Oncolytics Biotech Inc. Research Collaborators Present Combination Reovirus and Cyclophosphamide Treatment Results at International Oncolytic Virus Conference

Mar 16, 2007

Oncolytics Biotech Inc. Research Collaborators to Present Combination Reovirus and Cisplatin Treatment Results at Oncolytic Virus Conference